{"id":1825,"date":"2017-05-23T17:54:58","date_gmt":"2017-05-23T21:54:58","guid":{"rendered":"https:\/\/cqdm.org\/en\/news-and-events\/new-program-synergiqc\/"},"modified":"2024-09-25T16:29:22","modified_gmt":"2024-09-25T20:29:22","slug":"new-program-synergiqc","status":"publish","type":"post","link":"https:\/\/cqdm.org\/en\/news-and-events\/new-program-synergiqc\/","title":{"rendered":"NEW PROGRAM: SYNERGIQC"},"content":{"rendered":"\n<section>\n<div class=\"content\">\n<div class=\"l-container\">\n<div class=\"content-body s-3-tmargin\">\n<p style=\"text-align: left;\"><strong>The&nbsp;CQDM is expanding its financing activities&nbsp;in<\/strong><strong>&nbsp;all&nbsp;fields of biopharmaceutical research in Quebec<\/strong><\/p>\n<p>Montr\u00e9al, May 23 2017 \u2013 The CQDM is proud to be launching its new&nbsp;<strong><em>SynergiQc<\/em><\/strong>&nbsp;program, designed to stimulate industrial research in the biopharmaceutical field within academic settings and to create economic benefits for Quebec.<\/p>\n<p><strong><em>SynergiQc<\/em><\/strong>&nbsp;aims to support Quebec companies, through the financing of academic research focused on their industrial innovation needs, by fostering the development of biopharmaceutical products with high industrial and commercial value, leading to the creation of economic value.<\/p>\n<p>With the&nbsp;<strong><em>SynergiQc&nbsp;<\/em><\/strong>program, CQDM\u2019s funding offer, which has traditionally been limited to platforms and tools designed to improve biopharmaceutical R&amp;D productivity, will now extend to include all areas of biopharmaceutical research, including new molecules and other technology considered more competitive.<\/p>\n<p>In addition,&nbsp;<strong><em>SynergiQc<\/em><\/strong>&nbsp;provides an opportunity to finance projects with new industrial members, from biotechs to service companies and global pharmaceutical companies to start-ups, as well as CQDM\u2019s current pharmaceutical members.<\/p>\n<p>\u201c<strong><em>SynergiQc<\/em><\/strong>&nbsp;is able to support a large number of companies\u201d, says Marc Thibault, CQDM\u2019s Director of Programs. \u201c<strong><em>SynergiQc<\/em><\/strong>&nbsp;targets all Qu\u00e9bec businesses that are looking to innovate in order to stand out locally and internationally by benefitting from the inventive expertise of biopharmaceutical researchers working in academic settings.\u201c<\/p>\n<p>Whether as part of a consortium (for start-up projects) or on an exclusive basis (for more advanced projects),&nbsp;<strong><em>SynergiQc<\/em><\/strong>&nbsp;provides flexibility for various companies to work with, and financially participate in, various academic collaboration projects meeting their specific needs.<\/p>\n<p>In doing so,&nbsp;<strong><em>SynergiQc<\/em><\/strong>&nbsp;will increase the number of cooperative endeavours and partnerships between Qu\u00e9bec\u2019s universities and companies in the life sciences industry.<\/p>\n<p>\u201c<strong><em>SynergiQc<\/em><\/strong>&nbsp;reflects CQDM\u2019s vision, which indicates that to truly innovate and find solutions to complex issues, we must look to multi-disciplinary and multi-institutional collaborations occurring through public-private partnerships\u201d, adds Mario Chevrette, CQDM\u2019s Vice President of Scientific Affairs.<\/p>\n<p>To view the call for proposals, search for the Program tab on the CQDM\u2019s website at&nbsp;<a href=\"https:\/\/cqdm.org\">www.cqdm.org<\/a>.<\/p>\n<p><em>About the CQDM<\/em><\/p>\n<p><em>Since its inception in 2008, the CQDM, a non-profit biopharmaceutical research consortium and an industrial research cluster, has been driven by the mission to fund projects which accelerate the development of drugs. It does so in conjunction with its partners in the pharmaceutical industry, the same companies which contributed to its creation.<\/em><\/p>\n<p><em>With&nbsp;<strong>SynergiQc<\/strong>, the CQDM is diversifying its financing activities in order to support a larger number of companies and to expand its pool of industrial members which participate in projects.<\/em><\/p>\n<p><em>The CQDM is a catalyst where academia, governments, and the life sciences industry converge to create practical solutions to complex medical challenges.<\/em><\/p>\n<p><em>The CQDM is funded by its industrial and pharmaceutical members as well as the Quebec government\u2019s Ministry of Economy, Science and Innovation (MESI) and the Canadian government\u2019s Business-Led Networks of Centres of Excellence (BL-NCE).<\/em><\/p>\n<p>-30-<\/p>\n<p><em>Source and information:&nbsp;<\/em><a href=\"https:\/\/cqdm.org\"><em>www.cqdm.org<\/em><\/a><em>.<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>The&nbsp;CQDM is expanding its financing activities&nbsp;in&nbsp;all&nbsp;fields of biopharmaceutical research in Quebec Montr\u00e9al, May 23 2017 \u2013 The CQDM is proud to be launching its new&nbsp;SynergiQc&nbsp;program, designed to stimulate industrial research in the biopharmaceutical field within academic settings and to create economic benefits for Quebec. SynergiQc&nbsp;aims to support Quebec companies, through the financing of academic research&hellip;<\/p>\n","protected":false},"author":2,"featured_media":851,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1825","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-our-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/1825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/comments?post=1825"}],"version-history":[{"count":1,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/1825\/revisions"}],"predecessor-version":[{"id":4400,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/1825\/revisions\/4400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media\/851"}],"wp:attachment":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media?parent=1825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/categories?post=1825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/tags?post=1825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}